T1	SectionAnnotate 178 182	HPI:
T2	SectionAnnotate 4151 4165	Social History
T4	SectionAnnotate 18852 18883	Assessment and Recommendations:
T5	PROBLEM 79 92	breast cancer
T6	TREATMENT 134 151	treatment options
T7	TEST 204 225	a screening mammogram
T8	PROBLEM 274 309	heterogeneously dense breast tissue
T9	PROBLEM 330 340	malignancy
T10	PROBLEM 360 394	a painful mass in her right breast
T11	PROBLEM 484 502	a firm mobile mass
T12	PROBLEM 563 589	dimpling of overlying skin
T13	TEST 596 618	A diagnostic mammogram
T14	PROBLEM 644 679	heterogeneously dense breast tissue
T15	PROBLEM 684 722	a round, indistinct, high density mass
T16	PROBLEM 753 770	the palpable lump
T17	TEST 833 854	A targeted ultrasound
T18	PROBLEM 884 917	a hypoechoic irregular solid mass
T19	TREATMENT 1032 1069	a right breast fine needle aspiration
T20	TEST 1106 1119	The pathology
T21	PROBLEM 1140 1154	adenocarcinoma
T22	TEST 1160 1162	ER
T23	TEST 1173 1175	PR
T24	TEST 1190 1194	HER2
T25	TEST 1205 1208	IHC
T26	Pathology 1212 1222	FISH ratio
T27	TREATMENT 1304 1329	breast conserving surgery
T28	TREATMENT 1345 1355	mastectomy
T29	TREATMENT 1378 1387	radiation
T30	TREATMENT 1406 1438	a right breast simple mastectomy
T31	TEST 1443 1469	sentinel lymph node biopsy
T32	TEST 1499 1512	The pathology
T33	PROBLEM 1539 1550	grade 3 IDC
T34	TEST 1553 1570	The mitotic count
T35	PROBLEM 1575 1589	quite elevated
T36	PROBLEM 1662 1685	lymphovascular invasion
T37	PROBLEM 1704 1708	DCIS
T38	TEST 1730 1756	the 2 sentinel lymph nodes
T39	PROBLEM 1774 1788	adenocarcinoma
T40	PROBLEM 1805 1825	extranodal extension
T41	TEST 1829 1839	Biomarkers
T42	TEST 1857 1874	estrogen receptor
T43	TEST 1885 1906	progesterone receptor
T44	TEST 1917 1921	HER2
T45	TEST 1932 1935	IHC
T46	TEST 1939 1949	FISH ratio
T47	TEST 1966 1970	HER2
T48	TEST 1975 1978	nuc
T49	TEST 1987 2000	Cen17 sig/nuc
T50	PROBLEM 2011 2035	variable Ki67 expression
T51	TEST 2052 2059	average
T52	PROBLEM 2088 2095	dyspnea
T53	PROBLEM 2176 2209	her known congestive hart failure
T54	PROBLEM 2215 2243	left venrticular dysfunction
T55	TEST 2245 2249	LVEF
T56	MedicationName 2278 2283	Lasix
T57	PROBLEM 2480 2487	dyspnea
T58	PROBLEM 2501 2505	pain
T59	TREATMENT 2521 2539	her breast surgery
T60	TREATMENT 2589 2606	Cardiac pacemaker
T61	PROBLEM 2620 2664	Cataract     CHF (congestive heart failure)
T62	PROBLEM 2670 2698	CKD (chronic kidney disease)
T63	PROBLEM 2703 2725	Chronic kidney disease
T64	PROBLEM 2727 2731	CKD)
T65	PROBLEM 2732 2744	stage G3b/A1
T66	PROBLEM 2746 2793	moderately decreased glomerular filtration rate
T67	TEST 2795 2798	GFR
T68	TEST 2826 2838	square meter
T69	TEST 2843 2854	albuminuria
T70	TEST 2855 2871	creatinine ratio
T71	PROBLEM 2894 2948	Coronary atherosclerosis of unspecified type of vessel
T72	TREATMENT 2960 2965	graft
T73	PROBLEM 2971 2988	Diabetes mellitus
T74	PROBLEM 3006 3044	GERD (gastroesophageal reflux disease)
T75	PROBLEM 3050 3058	Glaucoma
T76	PROBLEM 3075 3093	HTN (hypertension)
T77	PROBLEM 3099 3111	Hypertension
T78	PROBLEM 3117 3153	Other and unspecified hyperlipidemia
T79	TREATMENT 3159 3168	Pacemaker
T80	PROBLEM 3174 3202	SBO (small bowel obstruction
T81	PROBLEM 3208 3219	Partial sbo
T82	TREATMENT 3239 3267	previous abdominal surgeries
T83	PROBLEM 3300 3321	small occult neoplasm
T84	PROBLEM 3325 3340	focal enteritis
T85	PROBLEM 3342 3350	Adhesion
T86	TREATMENT 3376 3395	abdominal surgeries
T87	TEST 3397 3400	EGD
T88	PROBLEM 3430 3449	Sick sinus syndrome
T89	TREATMENT 3512 3536	BIOPSY / EXCISION BREAST
T90	TREATMENT 3543 3575	CHOLECYSTECTOMY      MASTECTOMY
T91	TREATMENT 3597 3616	PACEMAKER INSERTION
T92	TEST 3627 3653	SENTINEL LYMPH NODE BIOPSY
T93	PROBLEM 3729 3735	Stroke
T94	PROBLEM 3748 3762	Uterine cancer
T95	PROBLEM 3792 3798	Stroke
T96	PROBLEM 3811 3819	Diabetes
T97	PROBLEM 3831 3840	Arthritis
T98	PROBLEM 3852 3858	Stroke
T99	PROBLEM 3888 3902	Stomach cancer
T100	PROBLEM 3931 3945	Uterine cancer
T101	PROBLEM 3982 3991	Blindness
T102	PROBLEM 4004 4013	Amblyopia
T103	PROBLEM 4026 4035	Cataracts
T104	PROBLEM 4048 4056	Glaucoma
T105	PROBLEM 4069 4082	Macular degen
T106	PROBLEM 4095 4113	Retinal detachment
T107	PROBLEM 4126 4136	Strabismus
T108	TREATMENT 4756 4765	menopause
T109	PROBLEM 4796 4799	HRT
T110	TREATMENT 4897 4920	acetaminophen (TYLENOL)
T111	PROBLEM 5004 5013	MILD PAIN
T112	TREATMENT 5022 5042	amLODIPine (NORVASC)
T113	TREATMENT 5119 5126	aspirin
T114	TREATMENT 5188 5210	atorvastatin (LIPITOR)
T115	TREATMENT 5273 5292	bisoprolol (ZEBETA)
T116	TEST 5352 5365	blood glucose
T117	TREATMENT 5366 5381	(BLOOD GLUCOSE)
T118	TEST 5382 5392	test strip
T119	TEST 5399 5410	blood sugar
T120	TEST 5451 5475	blood glucose monitoring
T121	TEST 5486 5497	blood sugar
T122	TREATMENT 5523 5545	brimonidine (ALPHAGAN)
T123	TREATMENT 5634 5668	calcium carbonate-vitamin D (OYSCO
T124	TREATMENT 5769 5790	glipiZIDE (GLUCOTROL)
T125	TREATMENT 5871 5896	insulin glargine (LANTUS)
T126	TREATMENT 5983 6011	insulin syringe-needle U-100
T127	TREATMENT 6130 6151	latanoprost (XALATAN)
T128	TREATMENT 6242 6264	metFORMIN (GLUCOPHAGE)
T129	TREATMENT 6349 6367	valsartan (DIOVAN)
T130	TREATMENT 6426 6436	ALPHAGAN P
T131	TREATMENT 6514 6538	docusate sodium (COLACE)
T132	TREATMENT 6623 6644	loratadine (CLARITIN)
T133	TREATMENT 6718 6738	mometasone (NASONEX)
T134	TREATMENT 6804 6829	nitroGLYCERIN (NITROSTAT)
T135	PROBLEM 6931 6941	Chest pain
T136	TREATMENT 6960 6981	olopatadine (PATANOL)
T137	TREATMENT 7098 7119	doxycycline (MONODOX)
T138	TREATMENT 7157 7175	furosemide (LASIX)
T139	TREATMENT 7266 7288	oxyCODONE (ROXICODONE)
T140	PROBLEM 7372 7376	Pain
T141	TREATMENT 7426 7437	Medications
T142	TREATMENT 7457 7562	Medication Dose Route Frequency Provider Last Rate Last Dose    [COMPLETED] furosemide (LASIX) injection
T143	TREATMENT 7657 7698	% sodium chloride flush injection syringe
T144	TREATMENT 7799 7842	% sodium 
 chloride flush injection syringe
T145	TREATMENT 7915 7938	acetaminophen (TYLENOL)
T146	TREATMENT 8024 8047	acetaminophen (TYLENOL)
T147	TREATMENT 8133 8153	amLODIPine (NORVASC)
T148	TREATMENT 8242 8259	aspirin EC tablet
T149	TREATMENT 8339 8361	atorvastatin (LIPITOR)
T150	TREATMENT 8463 8485	brimonidine (ALPHAGAN)
T151	TREATMENT 8613 8621	dextrose
T152	TREATMENT 8732 8764	docusate sodium (COLACE) capsule
T153	TREATMENT 8861 8882	glipiZIDE (GLUCOTROL)
T154	TREATMENT 8979 8995	glucose chewable
T155	TREATMENT 9081 9105	insulin aspart (NovoLOG)
T156	TREATMENT 9241 9265	insulin aspart (NovoLOG)
T157	TREATMENT 9411 9446	insulin glargine (LANTUS, BASAGLAR)
T158	TREATMENT 9577 9598	latanoprost (XALATAN)
T159	TREATMENT 9732 9753	loratadine (CLARITIN)
T160	TREATMENT 9842 9864	metFORMIN (GLUCOPHAGE)
T161	TREATMENT 9980 10005	nitroGLYCERIN (NITROSTAT)
T162	TREATMENT 10006 10015	SL tablet
T163	TREATMENT 10103 10123	ondansetron (ZOFRAN)
T164	TREATMENT 10215 10235	ondansetron (ZOFRAN)
T165	TREATMENT 10317 10335	valsartan (DIOVAN)
T166	PROBLEM 10465 10477	some fatigue
T167	PROBLEM 10517 10531	vision changes
T168	TEST 10534 10538	HENT
T169	PROBLEM 10560 10575	nasal discharge
T170	PROBLEM 10579 10595	sinus tenderness
T171	PROBLEM 10600 10621	difficulty swallowing
T172	PROBLEM 10626 10637	mouth sores
T173	PROBLEM 10642 10653	sore throat
T174	PROBLEM 10668 10679	breast pain
T175	PROBLEM 10695 10702	dyspnea
T176	PROBLEM 10719 10724	cough
T177	PROBLEM 10729 10737	wheezing
T178	PROBLEM 10760 10770	chest pain
T179	PROBLEM 10775 10787	palpitations
T180	PROBLEM 10792 10813	lower extremity edema
T181	PROBLEM 10821 10833	constipation
T182	PROBLEM 10838 10847	heartburn
T183	PROBLEM 10852 10858	nausea
T184	PROBLEM 10863 10869	emesis
T185	Symptom 10874 10888	abdominal pain
T186	Symptom 10893 10901	diarrhea
T187	Symptom 10906 10912	melena
T188	Symptom 10917 10929	hematochezia
T189	Symptom 10940 10955	suprapubic pain
T190	Symptom 10960 10967	dysuria
T191	Symptom 10972 10988	vaginal bleeding
T192	Symptom 11009 11024	joint stiffness
T193	Symptom 11029 11040	muscle pain
T194	Symptom 11045 11054	bone pain
T195	Symptom 11072 11093	heat/cold intolerance
T196	Symptom 11098 11109	hot flashes
T197	TEST 11116 11121	Lymph
T198	Symptom 11127 11140	easy bruising
T199	Symptom 11141 11149	bleeding
T200	Symptom 11154 11164	lymphedema
T201	Symptom 11185 11194	headaches
T202	Symptom 11199 11208	dizziness
T203	Symptom 11213 11221	numbness
T204	Symptom 11222 11230	tingling
T205	PROBLEM 11235 11240	falls
T206	Symptom 11259 11266	anxious
T207	Symptom 11271 11281	depression
T208	Symptom 11294 11300	rashes
T209	PROBLEM 11301 11308	lesions
T210	Symptom 11313 11324	diaphoresis
T211	TEST 11348 11352	ECOG
T212	TEST 11357 11368	Vital Signs
T213	TEST 11371 11373	BP
T214	TEST 11383 11388	Pulse
T215	TEST 11394 11398	Temp
T216	TEST 11404 11405	C
T217	TEST 11425 11429	Resp
T218	TEST 11435 11437	Ht
T219	TEST 11485 11487	Wt
T220	TEST 11507 11511	SpO2
T221	TEST 11518 11521	BMI
T222	PROBLEM 11559 11562	NAD
T223	PROBLEM 11578 11587	anicteric
T224	PROBLEM 11617 11626	nontender
T225	PROBLEM 11665 11673	erythema
T226	PROBLEM 11675 11685	stomatitis
T227	PROBLEM 11690 11710	thrush   Lymph Nodes
T228	PROBLEM 11716 11770	cervical, supraclavicular, or axillary lymphadenopathy
T229	TEST 11802 11812	percussion
T230	TEST 11825 11828	CTA
T231	PROBLEM 11845 11852	wheezes
T232	PROBLEM 11854 11861	rhonchi
T233	PROBLEM 11866 11874	crackles
T234	PROBLEM 11930 11937	murmurs
T235	PROBLEM 11942 11947	edema
T236	TREATMENT 11958 11981	right simple mastectomy
T237	PROBLEM 11986 12005	mass in left breast
T238	PROBLEM 12042 12052	tenderness
T239	PROBLEM 12057 12067	distention
T240	PROBLEM 12072 12075	HSM
T241	PROBLEM 12098 12129	tenderness over bones or joints
T242	PROBLEM 12250 12252	HI
T243	PROBLEM 12254 12256	SI
T244	PROBLEM 12258 12272	hallucinations
T245	PROBLEM 12274 12282	paranoia
T246	PROBLEM 12287 12296	delusions
T247	PROBLEM 12318 12324	rashes
T248	PROBLEM 12328 12335	lesions
T249	TEST 12352 12366	Available labs
T250	TEST 12368 12377	pathology
T251	TEST 12383 12390	imaging
T252	TEST 12506 12515	WBC Count
T253	TEST 12534 12544	Hemoglobin
T254	TEST 12567 12577	Hematocrit
T255	TEST 12601 12615	Platelet Count
T256	TEST 12635 12646	Lab Results
T257	TEST 12659 12664	Value
T258	TEST 12673 12679	Sodium
T259	TEST 12681 12686	Serum
T260	TEST 12689 12695	Plasma
T261	TEST 12718 12727	Potassium
T262	TEST 12729 12734	Serum
T263	TEST 12737 12743	Plasma
T264	TEST 12762 12770	Chloride
T265	TEST 12772 12777	Serum
T266	TEST 12780 12786	Plasma
T267	TEST 12805 12819	Carbon Dioxide
T268	TEST 12821 12826	Total
T269	TEST 12844 12857	Urea Nitrogen
T270	TEST 12859 12873	Serum / Plasma
T271	TEST 12891 12901	Creatinine
T272	TEST 12925 12932	Glucose
T273	TEST 13007 13014	Calcium
T274	TEST 13023 13028	Serum
T275	TEST 13031 13037	Plasma
T276	TEST 13057 13068	Lab Results
T277	TEST 13071 13086	Component Value
T278	TEST 13095 13104	Aspartate
T279	TEST 13105 13117	transaminase
T280	TEST 13135 13155	Alanine transaminase
T281	TEST 13173 13193	Alkaline Phosphatase
T282	TEST 13211 13220	Bilirubin
T283	TEST 13222 13227	Total
T284	TEST 13246 13253	Albumin
T285	TEST 13255 13260	Serum
T286	TEST 13263 13269	Plasma
T287	TREATMENT 13660 13691	Right breast, simple mastectomy
T288	PROBLEM 13698 13723	Invasive ductal carcinoma
T289	PROBLEM 13786 13799	Fibroadenomas
T290	PROBLEM 13805 13831	Cystic dilatation of ducts
T291	PROBLEM 13836 13855	apocrine metaplasia
T292	PROBLEM 13861 13875	Calcifications
T293	PROBLEM 13892 13911	apocrine metaplasia
T294	PROBLEM 13916 13928	benign ducts
T295	TEST 14009 14025	1- ex vivo count
T296	TEST 14032 14038	biopsy
T297	PROBLEM 14042 14080	Metastatic carcinoma in one lymph node
T298	PROBLEM 14093 14113	extranodal extension
T299	TEST 14196 14202	biopsy
T300	PROBLEM 14207 14231	tumor  in one lymph node
T301	PROBLEM 14290 14317	Benign fibroadipose  tissue
T302	PROBLEM 14322 14331	carcinoma
T303	PROBLEM 14368 14379	Benign skin
T304	PROBLEM 14384 14393	carcinoma
T305	PROBLEM 14477 14497	Upper outer quadrant
T306	PROBLEM 14550 14575	Invasive ductal carcinoma
T307	TEST 14580 14599	Invasive tumor size
T308	PROBLEM 14612 14622	Tumor size
T309	PROBLEM 14643 14648	tumor
T310	PROBLEM 14730 14749	Invasive tumor size
T311	TREATMENT 14756 14775	neoadjuvant therapy
T312	PROBLEM 14785 14805	Invasive tumor grade
T313	TEST 14886 14899	Mitotic count
T314	PROBLEM 14926 14959	Glandular/tubular differentiation
T315	TEST 15013 15049	EIC (extensive intraductal component
T316	PROBLEM 15065 15092	Lymphatic/vascular invasion
T317	PROBLEM 15117 15141	lymphovascular  invasion
T318	PROBLEM 15181 15215	significant pathologic abnormality
T319	PROBLEM 15240 15274	significant pathologic abnormality
T320	PROBLEM 15291 15305	invasive tumor
T321	PROBLEM 15350 15355	tumor
T322	PROBLEM 15416 15421	tumor
T323	PROBLEM 15469 15474	tumor
T324	TEST 15497 15521	Anterior/superior margin
T325	TEST 15579 15603	Anterior/inferior margin
T326	PROBLEM 15615 15620	tumor
T327	PROBLEM 15657 15673	Ductal carcinoma
T328	PROBLEM 15699 15718	Microcalcifications
T329	PROBLEM 15744 15763	apocrine metaplasia
T330	PROBLEM 15769 15781	benign ducts
T331	PROBLEM 15786 15803	Lobular carcinoma
T332	PROBLEM 15822 15843	Non-neoplastic breast
T333	PROBLEM 15845 15871	Cystic dilatation of ducts
T334	PROBLEM 15873 15893	apocrine  metaplasia
T335	PROBLEM 15895 15908	fibroadenomas
T336	TEST 16018 16033	micrometastases
T337	TEST 16072 16087	macrometastases
T338	PROBLEM 16107 16133	largest metastasis in node
T339	TEST 16213 16228	Tumor biomarker
T340	PROBLEM 16316 16341	palpable, pink-white mass
T341	PROBLEM 16347 16365	irregular  borders
T342	PROBLEM 16578 16602	a pink, dark-yellow area
T343	TREATMENT 16633 16653	a prior  biopsy site
T344	PROBLEM 16658 16724	A small (0.5 cm greatest dimension) orange-yellow translucent bead
T345	TREATMENT 16797 16806	The  bead
T346	TREATMENT 16821 16843	tissue paper and gauze
T347	TEST 16917 16924	Margins
T348	TEST 16928 16951	Anterior/superior: Mass
T349	PROBLEM 16994 17017	Anterior/inferior: Mass
T350	PROBLEM 17061 17065	Mass
T351	PROBLEM 17099 17103	Mass
T352	PROBLEM 17134 17138	Mass
T353	PROBLEM 17187 17191	Mass
T354	PROBLEM 17228 17232	Mass
T355	TREATMENT 17248 17272	lateral skin ellipse tip
T356	PROBLEM 17289 17306	nipple retraction
T357	PROBLEM 17310 17315	crust
T358	PROBLEM 17330 17353	a blue discolored  area
T359	PROBLEM 17423 17431	a bruise
T360	PROBLEM 17436 17441	scars
T361	PROBLEM 17529 17560	lobular 
 yellow adipose tissue
T362	PROBLEM 17593 17601	the mass
T363	PROBLEM 17613 17641	mixed yellow adipose  tissue
T364	PROBLEM 17652 17670	white, firm tissue
T365	TREATMENT 17740 17746	a clip
T366	TEST 18078 18103	Immunohistochemical tests
T367	TREATMENT 18108 18143	estrogen and progesterone receptors
T368	TEST 18145 18149	HER2
T369	TEST 18155 18160	Ki-67
T370	TEST 18214 18245	The test for estrogen receptors
T371	PROBLEM 18271 18303	nuclear  staining in tumor cells
T372	TREATMENT 18305 18330	Internal positive control
T373	TEST 18393 18428	The test for progesterone receptors
T374	PROBLEM 18454 18486	nuclear  staining in tumor cells
T375	TREATMENT 18488 18513	Internal positive control
T376	TEST 18586 18595	HER2 test
T377	PROBLEM 18597 18611	This carcinoma
T378	PROBLEM 18628 18661	HER2 oncoprotein  over-expression
T379	PROBLEM 18689 18703	this carcinoma
T380	TEST 18733 18758	Ki-67 proliferation index
T381	TEST 18760 18779	Variable expression
T382	ClinicalCondition 18921 18951	multiple medical comorbidities
T383	ClinicalCondition 18963 18976	heart failure
T384	TEST 18982 18986	LVEF
T385	PROBLEM 18995 19000	DM II
T386	PROBLEM 19039 19086	a Stage II (T2N1) triple negative breast cancer
T387	TEST 19100 19118	additional testing
T388	PROBLEM 19231 19260	triple negative breast cancer
T389	TEST 19303 19310	imaging
T390	TreatmentType 19338 19350	chemotherapy
T391	TREATMENT 19376 19385	treatment
T392	PROBLEM 19390 19419	triple negative breast cancer
T393	TreatmentType 19450 19462	chemotherapy
T394	PROBLEM 19482 19495	Stage II TNBC
T395	PROBLEM 19515 19549	her multiple medical comorbidities
T396	TREATMENT 19582 19607	our chemotherapy regimens
T397	TREATMENT 19744 19748	AC/T
T398	PROBLEM 19792 19809	her heart failure
T399	PROBLEM 19858 19875	her heart failure
T400	Symptom 19883 19895	fluid shifts
T401	PROBLEM 19907 19919	her diabetes
T402	TREATMENT 19934 19947	dexamethasone
T403	Symptom 19976 19986	less toxic
T404	DiseaseState 20053 20063	recurrence
T405	PROBLEM 20140 20167	a high grade, node positive
T406	PROBLEM 20169 20198	triple negative breast cancer
T407	DiseaseState 20214 20224	recurrence
T408	TEST 20292 20307	staging imaging
T409	PROBLEM 20322 20332	metastasis
T410	PROBLEM 20392 20403	her disease
T411	TREATMENT 20463 20488	a lower risk chemotherapy
T412	PROBLEM 20512 20522	metastasis
T413	PROBLEM 20554 20578	her other medical issues
T414	Metastasis 20662 20672	metastases
T415	Radiology 20689 20697	a PET/CT
T416	TREATMENT 20742 20751	treatment
T417	Radiology 20806 20812	PET/CT
T418	TREATMENT 20950 20968	the treatment plan
T419	TREATMENT 20985 21001	medication risks
T420	PROBLEM 21003 21011	symptoms
T421	TREATMENT 21016 21035	therapeutic options
T422	ClinicalCondition 29 43	postmenopausal
A1	ChronicVal T422 chronic
T423	ClinicalCondition 86 92	cancer
T424	Radiology 216 225	mammogram
A2	IntentVal T424 screening
T425	Datetime 229 237	11/06/11
T426	RadPathResult 274 295	heterogeneously dense
A3	RadPathResultVal T426 NoDisease
R1	ResultOfTest Desc:T426 Test:T424	
T427	Site 296 302	breast
R2	SiteOf Arg1:T427 Arg2:T426	
R3	SiteOf Arg1:T427 Arg2:T424	
T428	RadPathResult 330 340	malignancy
A4	NegationModalityVal T428 negated
A5	RadPathResultVal T428 NoDisease
R4	ResultOfTest Desc:T428 Test:T424	
T429	Datetime 398 409	August 2016
T430	Symptom 362 374	painful mass
A6	IsPresentOnFirstCancerDiagnosis T430 yes
A7	IsCausedByDiagnosedCancer T430 yes
A8	ChronicVal T430 non-chronic
A9	ContinuityVal T430 new
T431	Site 388 394	breast
T432	Laterality 382 387	right
R5	LateralityOfSite Arg1:T432 Arg2:T431	
R6	SiteOf Arg1:T431 Arg2:T430	
T433	Datetime 465 473	09/11/16
T434	Symptom 486 502	firm mobile mass
A10	IsPresentOnFirstCancerDiagnosis T434 yes
A11	IsCausedByDiagnosedCancer T434 yes
A12	ChronicVal T434 non-chronic
A13	ContinuityVal T434 new
T435	Size 504 508	6 cm
A14	HistoryVal T435 new
A15	EpisodeDescription T435 FirstOccurrence
T436	Site 523 557	upper outer quadrant of her breast
T437	Laterality 517 522	right
R7	LateralityOfSite Arg1:T437 Arg2:T436	
T438	Symptom 563 589	dimpling of overlying skin
A16	IsPresentOnFirstCancerDiagnosis T438 yes
A17	IsCausedByDiagnosedCancer T438 yes
A18	ChronicVal T438 non-chronic
A19	ContinuityVal T438 new
T439	Radiology 609 618	mammogram
A20	IntentVal T439 diagnosis
T440	Datetime 622 630	09/17/16
T441	RadPathResult 644 665	heterogeneously dense
A21	RadPathResultVal T441 Others
T442	Site 666 672	breast
T443	RadPathResult 686 722	round, indistinct, high density mass
A22	RadPathResultVal T443 InitialCancerDiagnosis
T444	Size 724 736	4.1 x 3.3 cm
R12	SiteOf Arg1:T442 Arg2:T439	
R13	ResultOfTest Desc:T443 Test:T439	
R9	ResultOfTest Desc:T441 Test:T439	
T445	Symptom 757 770	palpable lump
A23	IsPresentOnFirstCancerDiagnosis T445 yes
A24	IsCausedByDiagnosedCancer T445 yes
A25	ChronicVal T445 non-chronic
A26	ContinuityVal T445 new
T447	Site 789 800;807 830	upper outer breast, posterior depth
T448	Laterality 801 806	right
R15	LateralityOfSite Arg1:T448 Arg2:T447	
T450	Radiology 844 854	ultrasound
A27	IntentVal T450 diagnosis
T451	RadPathResult 886 917	hypoechoic irregular solid mass
A28	RadPathResultVal T451 InitialCancerDiagnosis
T452	Size 919 937	2.7 x 2.9 x 3.8 cm
A29	HistoryVal T452 new
A30	EpisodeDescription T452 FirstOccurrence
T453	Site 946 957	upper outer
T454	Site 964 970	breast
T455	Laterality 958 963	right
R17	LateralityOfSite Arg1:T455 Arg2:T454	
T456	Site 979 1015	10:00 position, 9 cm from the nipple
R18	LateralityOfSite Arg1:T455 Arg2:T456	
R19	LateralityOfSite Arg1:T455 Arg2:T453	
R20	ResultOfTest Desc:T451 Test:T450	
R21	TestOrProcedureReveals Test:T450 Desc:T452	
R22	SiteOf Arg1:T453 Arg2:T451	
R23	SiteOf Arg1:T454 Arg2:T451	
R24	SiteOf Arg1:T456 Arg2:T451	
T457	ProcedureName 1047 1069	fine needle aspiration
A31	IntentVal T457 diagnosis
T458	Site 1040 1046	breast
T459	Laterality 1034 1039	right
T460	Site 1077 1091	10:00 position
R25	LateralityOfSite Arg1:T459 Arg2:T460	
R26	LateralityOfSite Arg1:T459 Arg2:T458	
T461	Datetime 1095 1103	09/17/16
R27	SiteOf Arg1:T458 Arg2:T457	
R28	SiteOf Arg1:T460 Arg2:T457	
T462	Histology 1140 1154	adenocarcinoma
T463	BiomarkerName 1160 1162	ER
T464	BiomarkerResult 1163 1171	negative
*	BiomarkerRel T464 T463
T465	BiomarkerName 1173 1175	PR
T466	BiomarkerResult 1176 1184	negative
A32	BiomarkerResultVal T466 Negative
A33	BiomarkerResultVal T464 Negative
T467	BiomarkerName 1190 1194	HER2
A34	BiomarkerResultVal T467 Negative
*	BiomarkerRel T465 T466
A35	EpisodeDescription T467 FirstOccurrence
T468	BiomarkerResult 1195 1203	negative
A36	BiomarkerResultVal T468 Negative
*	BiomarkerRel T467 T468
T470	ProcedureName 1304 1329	breast conserving surgery
A38	NegationModalityVal T470 negated
A39	IntentVal T470 treatment-curative
A40	TreatmentTypeVal T470 local
T471	ProcedureName 1345 1355	mastectomy
A41	NegationModalityVal T471 affirmed
A42	IntentVal T471 treatment-curative
A43	TreatmentTypeVal T471 local
T472	RadiationTherapyName 1378 1387	radiation
A44	NegationModalityVal T472 negated
A45	TreatmentTypeVal T472 local
T473	ProcedureName 1421 1438	simple mastectomy
A46	IntentVal T473 treatment-curative
A47	TreatmentTypeVal T473 local
A48	IsTumorRemaining T473 unclear
T474	Datetime 1473 1481	10/25/16
T475	ProcedureName 1443 1469	sentinel lymph node biopsy
A49	IntentVal T475 DiagnosisAndTreatment
A50	TreatmentTypeVal T475 local
A51	IsTumorRemaining T475 unclear
T476	Size 1529 1535	3.6 cm
R29	TestOrProcedureReveals Test:T473 Desc:T476	
T477	Grade 1545 1546	3
T478	Histology 1547 1550	IDC
R30	TestOrProcedureReveals Test:T473 Desc:T477	
R31	TestOrProcedureReveals Test:T473 Desc:T478	
T479	RadPathResult 1557 1602	mitotic count was quite elevated at 74/10 hpf
R32	TestOrProcedureReveals Test:T473 Desc:T479	
T480	MarginStatus 1628 1636	negative
A52	MarginVal T480 MoreThan2mm(Neg)
T481	LocalInvasion 1662 1685	lymphovascular invasion
A53	NegationModalityVal T481 affirmed
T482	Site 1736 1756	sentinel lymph nodes
T483	LymphNodeInvolvement 1723 1726;1761 1769	One positive
A54	NegationModalityVal T483 affirmed
R33	TestOrProcedureReveals Test:T475 Desc:T483	
T484	Histology 1774 1788	adenocarcinoma
T485	Size 1790 1796	1.2 cm
R34	TestOrProcedureReveals Test:T475 Desc:T484	
R35	TestOrProcedureReveals Test:T475 Desc:T485	
T486	LocalInvasion 1805 1825	extranodal extension
A55	NegationModalityVal T486 negated
R36	TestOrProcedureReveals Test:T475 Desc:T486	
T487	BiomarkerName 1857 1874	estrogen receptor
T488	BiomarkerName 1885 1906	progesterone receptor
T489	BiomarkerName 1917 1921	HER2
T490	BiomarkerResult 1875 1883	negative
A56	BiomarkerResultVal T490 Negative
T491	BiomarkerResult 1907 1915	negative
A57	BiomarkerResultVal T491 Negative
T492	BiomarkerResult 1922 1930	positive
A58	BiomarkerResultVal T492 Positive
*	BiomarkerRel T489 T492
*	BiomarkerRel T488 T491
*	BiomarkerRel T487 T490
R37	TestOrProcedureReveals Test:T473 Desc:T487	
R38	TestOrProcedureReveals Test:T473 Desc:T488	
R39	TestOrProcedureReveals Test:T473 Desc:T489	
T495	Symptom 2088 2095	dyspnea
A60	IsPresentOnFirstCancerDiagnosis T495 no
A61	IsCausedByDiagnosedCancer T495 no
A62	ChronicVal T495 non-chronic
A63	ContinuityVal T495 new
T496	Datetime 2114 2122	11/20/16
T497	ClinicalCondition 2186 2209	congestive hart failure
A64	ChronicVal T497 chronic
A65	ContinuityVal T497 worsening
T498	ClinicalCondition 2215 2254	left venrticular dysfunction (LVEF 25%)
A66	ChronicVal T498 chronic
A67	ContinuityVal T498 stable
A68	TreatmentCategory T56 Others
T499	Symptom 2480 2487	dyspnea
A69	NegationModalityVal T499 negated
T500	Symptom 2501 2505	pain
A70	NegationModalityVal T500 negated
T502	Datetime 3413 3425	October 2012
T503	ProcedureName 3397 3405	EGD/Colo
A71	IntentVal T503 screening
T504	LivingCondition 4602 4625	Lives with her daughter
T505	ClinicalCondition 4677 4685	menarche
A72	NegationModalityVal T505 affirmed
A73	ChronicVal T505 non-chronic
A74	ContinuityVal T505 stopped
T506	Age 4689 4697	11 years
T507	ClinicalCondition 4735 4739	G7P5
T508	Symptom 10465 10477	some fatigue
A75	IsPresentOnFirstCancerDiagnosis T508 yes
A76	IsCausedByDiagnosedCancer T508 no
A77	ChronicVal T508 chronic
A78	ContinuityVal T508 stable
T509	Symptom 10517 10531	vision changes
A79	NegationModalityVal T509 negated
T510	Symptom 10560 10575	nasal discharge
A80	NegationModalityVal T510 negated
T511	Symptom 10579 10595	sinus tenderness
A81	NegationModalityVal T511 negated
T512	Symptom 10600 10621	difficulty swallowing
A82	NegationModalityVal T512 negated
T513	Symptom 10626 10637	mouth sores
A83	NegationModalityVal T513 negated
T514	Symptom 10642 10653	sore throat
A84	NegationModalityVal T514 negated
T515	Symptom 10675 10679	pain
A85	NegationModalityVal T515 negated
T516	Site 10668 10674	breast
R41	SiteOf Arg1:T516 Arg2:T515	
T517	Symptom 10695 10702	dyspnea
A86	IsPresentOnFirstCancerDiagnosis T517 yes
A87	IsCausedByDiagnosedCancer T517 no
A88	ChronicVal T517 chronic
A89	ContinuityVal T517 stable
T518	Symptom 10719 10724	cough
A90	NegationModalityVal T518 negated
T519	Symptom 10729 10737	wheezing
A91	NegationModalityVal T519 negated
T520	Symptom 10760 10770	chest pain
A92	NegationModalityVal T520 negated
T521	Symptom 10775 10787	palpitations
A93	NegationModalityVal T521 negated
T522	Symptom 10792 10813	lower extremity edema
A94	NegationModalityVal T522 negated
T523	Symptom 10821 10833	constipation
A95	IsPresentOnFirstCancerDiagnosis T523 yes
A96	IsCausedByDiagnosedCancer T523 no
A97	ContinuityVal T523 stable
T524	Symptom 10838 10847	heartburn
A98	NegationModalityVal T524 negated
T525	Symptom 10852 10858	nausea
A99	NegationModalityVal T525 negated
T526	Symptom 10863 10869	emesis
A100	NegationModalityVal T526 negated
A101	NegationModalityVal T185 negated
A102	NegationModalityVal T186 negated
A103	NegationModalityVal T187 negated
A104	NegationModalityVal T188 negated
A105	NegationModalityVal T189 negated
A106	NegationModalityVal T190 negated
A107	NegationModalityVal T191 negated
A108	NegationModalityVal T192 affirmed
A109	IsPresentOnFirstCancerDiagnosis T192 yes
A110	ChronicVal T192 chronic
A111	ContinuityVal T192 stable
A112	NegationModalityVal T193 negated
A113	NegationModalityVal T194 negated
A114	NegationModalityVal T195 negated
A115	NegationModalityVal T196 negated
A116	NegationModalityVal T198 negated
A117	NegationModalityVal T199 negated
A118	NegationModalityVal T200 negated
A119	NegationModalityVal T201 negated
A120	NegationModalityVal T202 negated
A121	NegationModalityVal T203 negated
A122	NegationModalityVal T204 negated
A123	NegationModalityVal T206 affirmed
A124	IsPresentOnFirstCancerDiagnosis T206 yes
A125	IsCausedByDiagnosedCancer T206 yes
A126	NegationModalityVal T207 negated
A127	NegationModalityVal T208 negated
A128	NegationModalityVal T210 negated
A129	NegationModalityVal T382 affirmed
A130	ChronicVal T382 chronic
A131	ContinuityVal T382 stable
A132	NegationModalityVal T383 affirmed
A133	ChronicVal T383 chronic
A134	ContinuityVal T383 stable
T527	ClinicalCondition 18982 18990	LVEF 25%
A135	NegationModalityVal T527 affirmed
A136	ChronicVal T527 chronic
A137	ContinuityVal T527 stable
T528	ClinicalCondition 18995 19000	DM II
A138	NegationModalityVal T528 affirmed
A139	ChronicVal T528 chronic
A140	ContinuityVal T528 stable
T529	Stage 19047 19049	II
T530	TNM 19051 19055	T2N1
A141	HistoryVal T530 new
A142	EpisodeDescription T530 FirstOccurrence
T532	ClinicalCondition 19080 19086	cancer
T533	BiomarkerResult 19238 19246	negative
A144	NegationModalityVal T390 hypothetical_in_future
A145	TreatmentTypeVal T390 adjuvant
T534	BiomarkerResult 19397 19405	negative
A146	NegationModalityVal T393 hypothetical_in_future
A147	TreatmentTypeVal T393 adjuvant
T535	Stage 19488 19490	II
T537	ClinicalCondition 19519 19549	multiple medical comorbidities
A148	ChronicVal T537 chronic
A149	ContinuityVal T537 stable
T538	TreatmentType 19586 19607	chemotherapy regimens
A150	NegationModalityVal T538 hypothetical_in_future
A151	TreatmentTypeVal T538 adjuvant
T539	Symptom 19631 19641	great harm
A152	NegationModalityVal T539 hypothetical_in_future
R42	ConditionOrTreatmentCausesProblem Treatment:T538 Prob:T539	
T540	MedicationRegimen 19744 19748	AC/T
A153	NegationModalityVal T540 hypothetical_in_future
A154	TreatmentTypeVal T540 adjuvant
A155	TreatmentIntentVal T540 curative
T541	ClinicalCondition 19796 19809	heart failure
A156	ChronicVal T541 chronic
A157	ContinuityVal T541 stable
T542	MedicationRegimen 19812 19814	TC
A158	NegationModalityVal T542 hypothetical_in_future
A159	TreatmentIntentVal T542 curative
T543	ClinicalCondition 19862 19875	heart failure
A160	ChronicVal T543 chronic
A161	ContinuityVal T543 stable
T544	ClinicalCondition 19911 19919	diabetes
A162	ChronicVal T544 chronic
A163	ContinuityVal T544 stable
T545	MedicationName 19934 19947	dexamethasone
A164	NegationModalityVal T545 hypothetical_in_future
A165	TreatmentCategory T545 Supportive
T546	MedicationRegimen 19962 19965	CMF
A166	NegationModalityVal T546 hypothetical_in_future
A167	TreatmentTypeVal T546 adjuvant
A168	TreatmentIntentVal T546 curative
A169	NegationModalityVal T403 hypothetical_in_future
R43	ConditionOrTreatmentCausesProblem Treatment:T546 Prob:T403	
T547	Symptom 20006 20016	great risk
A170	NegationModalityVal T547 hypothetical_in_future
R44	ConditionOrTreatmentCausesProblem Treatment:T546 Prob:T547	
T548	Symptom 19828 19839	not be safe
A171	NegationModalityVal T548 hypothetical_in_future
R45	ConditionOrTreatmentCausesProblem Treatment:T542 Prob:T548	
A172	NegationModalityVal T400 hypothetical_in_future
R46	ConditionOrTreatmentCausesProblem Treatment:T542 Prob:T400	
A173	NegationModalityVal T404 hypothetical_in_future
T549	Grade 20142 20146	high
A174	NegationModalityVal T549 affirmed
T550	LymphNodeInvolvement 20154 20167	node positive
A175	NegationModalityVal T550 affirmed
A176	HistoryVal T550 new
A177	EpisodeDescription T550 FirstOccurrence
A178	NegationModalityVal T407 hypothetical_in_future
T552	Radiology 20300 20307	imaging
A179	NegationModalityVal T552 hypothetical_in_future
A180	IntentVal T552 staging
T553	Metastasis 20322 20332	metastasis
A181	NegationModalityVal T553 hypothetical_in_future
R47	TestOrProcedureConductedForProblem Test:T552 Prob:T553	
T554	DiseaseState 20408 20422	already spread
A182	NegationModalityVal T554 hypothetical_in_future
T555	TreatmentType 20465 20488	lower risk chemotherapy
A183	NegationModalityVal T555 hypothetical_in_future
A184	TreatmentTypeVal T555 adjuvant
T556	Metastasis 20512 20522	metastasis
A185	NegationModalityVal T556 hypothetical_in_future
R48	TreatmentAdministeredForProblem Treatment:T555 Prob:T556	
A186	NegationModalityVal T414 hypothetical_in_future
A187	NegationModalityVal T415 planned_in_future
A188	IntentVal T415 staging
A189	NegationModalityVal T417 planned_in_future
R49	HappensAtOnDuring Arg1:T424 Arg2:T425	
T557	Age 242 250	76 years
R50	HappensAtOnDuring Arg1:T424 Arg2:T557	
R51	HappensAtOnDuring Arg1:T434 Arg2:T433	
R52	HappensAtOnDuring Arg1:T430 Arg2:T429	
R53	HappensAtOnDuring Arg1:T438 Arg2:T433	
R54	HappensAtOnDuring Arg1:T439 Arg2:T440	
R55	HappensAtOnDuring Arg1:T450 Arg2:T440	
R56	HappensAtOnDuring Arg1:T457 Arg2:T461	
R57	HappensAtOnDuring Arg1:T475 Arg2:T474	
R58	HappensAtOnDuring Arg1:T473 Arg2:T474	
R59	ProcedureDesc Procedure:T473 Desc:T480	
R60	HappensAtOnDuring Arg1:T495 Arg2:T496	
R61	HappensAtOnDuring Arg1:T503 Arg2:T502	
R62	BeginsOnOrAt Arg1:T505 Arg2:T506	
T558	ClinicalCondition 4756 4765	menopause
T559	Age 4769 4771	55
R63	BeginsOnOrAt Arg1:T558 Arg2:T559	
T560	SectionSkip 4808 5855;5858 7807;7810 9801;9804 10398	Outpatient Encounter Prescriptions as of 11/21/2016   Medication Sig Dispense Refill    acetaminophen (TYLENOL) 500 mg tablet Take 1 tablet (500 mg total) by mouth every 6 (six) hours as needed (MILD PAIN).      amLODIPine (NORVASC) 5 mg tablet Take 0.5 tablets (2.5 mg total) by mouth Daily. 90 tablet 3    aspirin 81 mg EC tablet TAKE 1 TABLET BY MOUTH DAILY 90 tablet 3    atorvastatin (LIPITOR) 40 mg tablet TAKE 1 TABLET BY MOUTH EVERY DAY 90 tablet 3    bisoprolol (ZEBETA) 5 mg tablet TAKE 1/2 TABLET BY MOUTH DAILY 50 tablet 3    blood glucose (BLOOD GLUCOSE) test strip Check blood sugar twice daily as directed. 180 each 3    blood glucose monitoring kit Check blood sugar as directed 1 each 0    brimonidine (ALPHAGAN) 0.1 % ophthalmic solution Place 1 drop into both eyes 2 (two) times daily. 10 mL 11    calcium carbonate-vitamin D (OYSCO 500/D) 1,250 mg (500 mg elemental)-200 unit tablet TAKE 1 TABLET BY MOUTH EVERY DAY 90 tablet 3    glipiZIDE (GLUCOTROL) 10 mg tablet TAKE 1 TABLET BY MOUTH TWICE DAILY BEFORE MEALS 180 tablet 1    insulin glargine (LANTUS) 100 unit/mL injection INJECT 5 UNITS INTO THE SKIN EVERY NIGHT AT BEDTIME 10 mL 5    insulin syringe-needle U-100 0.3 mL 29 SYRINGE USE DAILY AS DIRECTED 100 Syringe 3    lancets lancets Use twice daily as directed. 180 each 3    latanoprost (XALATAN) 0.005 % ophthalmic solution Place 1 drop into both eyes nightly at bedtime. 2.5 mL 11    metFORMIN (GLUCOPHAGE) 1,000 mg tablet TAKE 1 TABLET BY MOUTH TWICE DAILY TAKE WITH MEALS 200 tablet 3    valsartan (DIOVAN) 80 mg tablet TAKE 1 TABLET BY MOUTH DAILY 90 tablet 2    ALPHAGAN P 0.1 % ophthalmic solution INSTILL 1 DROP IN BOTH EYES TWICE DAILY 5 mL 0    docusate sodium (COLACE) 100 mg capsule Take 1 capsule (100 mg total) by mouth Twice a day. 60 capsule 0    loratadine (CLARITIN) 10 mg tablet Take 1 tablet (10 mg total) by mouth Daily. 90 tablet 1    mometasone (NASONEX) 50 mcg/actuation spray 2 sprays by Nasal route Daily. 17 g 6    nitroGLYCERIN (NITROSTAT) 0.4 mg SL tablet Place 1 tablet (0.4 mg total) under the tongue every 5 (five) minutes as needed for Chest pain. 100 tablet 3    olopatadine (PATANOL) 0.1 % ophthalmic solution Place 1 drop into both eyes daily as needed (1 drop as needed). 5 mL 6    [DISCONTINUED] doxycycline (MONODOX) 100 mg capsule       [DISCONTINUED] furosemide (LASIX) 40 mg tablet Take 0.5 tablets (20 mg total) by mouth Daily. 3 tablet 0    [DISCONTINUED] oxyCODONE (ROXICODONE) 5 mg tablet Take 1 tablet (5 mg total) by mouth every 4 (four) hours as needed for Pain. 30 tablet 0     Facility-Administered Encounter Medications as of 11/21/2016   Medication Dose Route Frequency Provider Last Rate Last Dose    [COMPLETED] furosemide (LASIX) injection 20 mg  20 mg Intravenous Once ***** *****, MD   20 mg at 11/20/16 1632    [DISCONTINUED] 0.9 % sodium chloride flush injection syringe  3 mL Intravenous Q8H SCH ***** ***** *****, *****-C   3 mL at 11/20/16 2138    [DISCONTINUED] 0.9 % sodium chloride flush injection syringe  3 mL Intravenous PRN ***** ***** *****, *****-C        [DISCONTINUED] acetaminophen (TYLENOL) tablet 500 mg  500 mg Oral Q6H PRN ***** ***** *****, *****-C        [DISCONTINUED] acetaminophen (TYLENOL) tablet 500 mg  500 mg Oral Q6H PRN ***** ***** *****, *****-C        [DISCONTINUED] amLODIPine (NORVASC) tablet 2.5 mg  2.5 mg Oral Daily (AM) ***** ***** *****, *****-C        [DISCONTINUED] aspirin EC tablet 81 mg  81 mg Oral Daily (AM) ***** ***** *****, *****-C        [DISCONTINUED] atorvastatin (LIPITOR) tablet 40 mg  40 mg Oral Q PM ***** ***** *****, *****-C   40 mg at 11/20/16 2128    [DISCONTINUED] brimonidine (ALPHAGAN) 0.1 % ophthalmic solution 1 drop  1 drop Both Eyes BID ***** ***** *****, *****-C   1 drop at 11/20/16 2128    [DISCONTINUED] dextrose 50% injection syringe 12.5 g  25 mL Intravenous Q15 Min PRN ***** ***** *****, *****-C        [DISCONTINUED] docusate sodium (COLACE) capsule 100 mg  100 mg Oral BID ***** ***** *****, *****-C   100 mg at 11/20/16 2128    [DISCONTINUED] glipiZIDE (GLUCOTROL) tablet 10 mg  10 mg Oral Daily with Breakfast ***** ***** *****, *****-C        [DISCONTINUED] glucose chewable tablet 20 g  20 g Oral Q15 Min PRN ***** ***** *****, *****-C        [DISCONTINUED] insulin aspart (NovoLOG) injection 100 units/mL pen  0-20 Units Subcutaneous TID ***** ***** ***** *****, *****-C   0 Units at 11/20/16 1843    [DISCONTINUED] insulin aspart (NovoLOG) injection 100 units/mL pen  0-3 Units Subcutaneous Bedtime and early am ***** ***** *****, *****-C   0 Units at 11/20/16 2134    [DISCONTINUED] insulin glargine (LANTUS, BASAGLAR) injection 100 units/mL pen  5 Units Subcutaneous Bedtime ***** ***** *****, *****-C   5 Units at 11/20/16 2136    [DISCONTINUED] latanoprost (XALATAN) 0.005 % ophthalmic solution 1 drop  1 drop Both Eyes Bedtime ***** ***** *****, *****-C   1 drop at 11/20/16 2128    [DISCONTINUED] loratadine (CLARITIN) tablet 10 mg  10 mg Oral Daily (AM) ***** ***** *****, *****-C        [DISCONTINUED] metFORMIN (GLUCOPHAGE) tablet 1,000 mg  1,000 mg Oral BID ***** ***** ***** *****, *****-C   1,000 mg at 11/20/16 1845    [DISCONTINUED] nitroGLYCERIN (NITROSTAT) SL tablet 0.4 mg  0.4 mg Sublingual Q5 Min PRN ***** ***** *****, *****-C        [DISCONTINUED] ondansetron (ZOFRAN) injection 4 mg  4 mg Intravenous Q8H PRN ***** ***** *****, *****-C        [DISCONTINUED] ondansetron (ZOFRAN) tablet 4 mg  4 mg Oral Q8H PRN ***** ***** *****, *****-C        [DISCONTINUED] valsartan (DIOVAN) tablet 80 mg  80 mg Oral Daily (AM) ***** ***** *****, *****-C
A193	SectionSkipType T560 medications
T561	SectionSkip 12468 13288	Lab Results   Component Value Date    WBC Count 9.9 11/20/2016    Hemoglobin 9.6 (L) 11/20/2016    Hematocrit 28.9 (L) 11/20/2016    Platelet Count 222 11/20/2016     Lab Results   Component Value Date    Sodium, Serum / Plasma 133 (L) 11/20/2016    Potassium, Serum / Plasma 4.2 11/20/2016    Chloride, Serum / Plasma 102 11/20/2016    Carbon Dioxide, Total 22 11/20/2016    Urea Nitrogen, Serum / Plasma 18 11/20/2016    Creatinine 1.01 (H) 11/20/2016    Glucose, non-fasting 201 (H) 11/20/2016     Lab Results   Component Value Date    Calcium, total, Serum / Plasma 9.4 11/20/2016     Lab Results   Component Value Date    Aspartate transaminase 27 11/20/2016    Alanine transaminase 19 11/20/2016    Alkaline Phosphatase 60 11/20/2016    Bilirubin, Total 0.9 11/20/2016    Albumin, Serum / Plasma 3.0 (L) 06/01/2015
A195	SectionSkipType T561 laboratory
T562	SectionSkip 11331 11771;11776 12466	Physical Exam:   ECOG 2   Vital Signs - BP 118/67 | Pulse 87 | Temp 36.3 C (97.3 F) (Oral)  | Resp 16 | Ht 150 cm (4' 11.06") Comment: 11/21/2016 ***** | Wt 53.5 kg (118 lb) | SpO2 98% | BMI 23.79 kg/m2   Constitutional - WDWN, NAD  Eyes - sclera anicteric, PERRL, EOMI  HENT - sinuses nontender, nasal mucosa intact, pharynx without erythema, stomatitis, or thrush   Lymph Nodes - no cervical, supraclavicular, or axillary lymphadenopathy. Respiratory - resonant to percussion throughout, CTA bilaterally; no wheezes, rhonchi, or crackles  Cardiovascular - Normal heart rate, normal rhythm, no murmurs, no edema  Breast - right simple mastectomy; no mass in left breast  GI - Bowel sounds normal, soft; no tenderness, no distention, no HSM  Musculoskeletal - No tenderness over bones or joints.   Neurologic - Alert & oriented x 3, ambulates w/o difficulty, good strength throughout  Psychiatric - Mood stable; no HI, SI, hallucinations, paranoia, or delusions  Skin - warm without rashes or lesions       Studies:  Available labs, pathology, and imaging were reviewed and independently interpreted, as described above in the HPI.
A196	SectionSkipType T562 physical_exam
T563	SectionSkip 13293 13736;13739 15636;15639 17536;17539 18845	10/25/16 SURGICAL PATHOLOGY REPORT    ***** WITH ADDENDUM *****    Patient Name: *****, *****  *****. Rec.#: *****  DOB: 04/22/1935 (Age: 81)  Sex: Female  Accession #: *****-*****  Visit #: *****  Service Date: 10/25/2016  Received: 10/25/2016  Location: PPE  Client:*****   Physician(s): ***** *****. ***** ((*****) *****-*****)    FINAL PATHOLOGIC DIAGNOSIS    A. Right breast, simple mastectomy:   1. Invasive ductal carcinoma, SBR   grade 3, 3.6 cm, negative margins;  see comment.  2. Fibroadenomas.  3. Cystic dilatation of ducts and apocrine metaplasia.  4. Calcifications associated with apocrine metaplasia and benign ducts.    5. Unremarkable skin and nipple.    B. Right axillary sentinel lymph node, #1- ex vivo count 5000, biopsy:   Metastatic carcinoma in one lymph node, 1.2 cm, no extranodal extension  (May 19); see comment.    C. Right axillary palpable non-sentinel lymph node #1, biopsy: No tumor  in one lymph node (0/1).    D. Right new anterior lateral margin, excision: Benign fibroadipose  tissue, no carcinoma.    E. Right breast skin, excision: Benign skin, no carcinoma.    COMMENT:  Breast Tumor Synoptic Comment    - Laterality: Right.  - Tumor site: Upper outer quadrant.    - Position: 10 o'clock.  - Invasive tumor type: Invasive ductal carcinoma.  - Invasive tumor size: 3.6 cm.  - Tumor size determined based on tumor present in 4 consecutive slides  (slice *****-*****, slice thickness 0.9 cm).  - Invasive tumor size after neoadjuvant therapy: N/A.  - Invasive tumor grade (modified Scarff-Bloom-Richardson): Grade 3.    - Nuclear grade: 3 points.    - Mitotic count: 74/10HPF: 3 points.    - Glandular/tubular differentiation: 3 points.    - Total points: 9 points = grade 3.  - EIC (extensive intraductal component): Negative.  - Lymphatic/vascular invasion: Features suggestive of lymphovascular  invasion present (slide A3).  - Skin/nipple: No significant pathologic abnormality.  - Skeletal muscle: No significant pathologic abnormality.  - Margins for invasive tumor: Negative.    - Posterior margin: Negative (tumor is 1.6 cm away, on slide A3).    - Medial margin: Negative (tumor is 12 cm away).    - Lateral margin: Negative (tumor is 2.4 cm away).    - Anterior/superior margin: Negative (tumor is <0.1 cm away, on  slide A4-A5).    - Anterior/inferior margin: Negative (tumor is 0.3 cm away, on  slide A6).  - Ductal carcinoma in situ (DCIS): None.  - Microcalcifications: Present associated with apocrine metaplasia and  benign ducts.  - Lobular carcinoma in situ: None.  - Non-neoplastic breast: Cystic dilatation of ducts, apocrine  metaplasia, fibroadenomas.  - Lymph node status: Positive.      - Total number of nodes examined: 2.      - Total number of nodes with micrometastases: 0.      - Total number of nodes with macrometastases: 1.      - Size of largest metastasis in node: 1.2 cm.      - Extranodal extension: None.    - AJCC/UICC stage: pT2N1a.    - Tumor biomarker (ER/PR/HER2) status: Will be reported by addendum.        GROSS ABNORMALITIES: A firm, palpable, pink-white mass with irregular  borders (2.6 cm medial-to-lateral x 3 cm superior-to-inferior x 2.8 cm  anterior-to-posterior; spanning slices 5 through 8) is present at 10  o'clock, approximately 7 cm from the nipple. The inferior tip of slice  9 has a pink, dark-yellow area (1 x 0.7 x 0.8 cm) resembling a prior  biopsy site.    A small (0.5 cm greatest dimension) orange-yellow translucent bead is  identified in slice 10 within white, firm fibrous-appearing tissue. The  bead is wrapped in tissue paper and gauze and placed with the remainder  of slice 10 in the specimen container.    Margins:  -Anterior/superior: Mass is <0.1 cm from margin (slice 6 and 7).  -Anterior/inferior: Mass is 0.1 cm from margin (***** 7).  -Medial: Mass is 12 cm from margin.  -Lateral: Mass is 2.4 cm from margin  -Deep: Mass is 1.5 cm from margin (slice 8).  -Nipple base: Mass is 8.4 cm from nipple base.  -Skin: Mass is 2.5 cm from lateral skin ellipse tip.    There is no nipple retraction or crust. The skin has a blue discolored  area (0.7 cm) immediately adjacent to the areola grossly consistent with  a bruise. No scars are seen. The deep surface is smooth and appears  complete. The anterior surfaces have lobular yellow adipose tissue.   The parenchyma uninvolved by the mass consist of mixed yellow adipose  tissue (70%) and white, firm tissue (30%). The specimen is radiographed  in the Pathology Department and a clip is not identified.    ***** *****/Pathology Resident  ***** *****/Pathologist    Electronically signed out on *****/*****/***** *****:*****      Addendum   Date Ordered:   10/31/2016   Status:  Signed Out    Date Complete:   10/31/2016   By: ***** *****    Date Reported:   10/31/2016     Addendum Diagnosis    Addendum Comment    Immunohistochemical tests for estrogen and progesterone receptors, HER2  and Ki-67 were performed by manual morphometry on block A4.    The test for estrogen receptors is negative. There is no nuclear  staining in tumor cells. Internal positive control is present, and  external positive control is appropriate.    The test for progesterone receptors is negative. There is no nuclear  staining in tumor cells. Internal positive control is present, and  external positive control is appropriate.    Result of HER2 test: This carcinoma is negative for HER2 oncoprotein  over-expression. The staining intensity of this carcinoma was 1 on a  scale of 0-3.    Ki-67 proliferation index: Variable expression ranging from <5% to  25-30%. Overall, it is estimated to be ~15%.
A197	SectionSkipType T563 pathology_report
T564	MaritalStatus 4205 4212	Married
T565	Tobacco 4383 4395	Never Smoker
A198	NegationModalityVal T565 negated
T566	Tobacco 4400 4429	Smokeless tobacco: Never Used
A199	NegationModalityVal T566 negated
T567	Alcohol 4434 4448	Alcohol use No
A200	NegationModalityVal T567 negated
T568	Drugs 4453 4465	Drug use: No
A201	NegationModalityVal T568 negated
T569	MaritalStatus 4572 4600	Married; husband still alive
R64	ExclusionCriteriaFor Arg1:T541 Arg2:T540	
R65	ExclusionCriteriaFor Arg1:T543 Arg2:T542	
A194	ChronicVal T423 non-chronic
A202	ContinuityVal T423 new
T3	Age 21 23	81
T570	Duration 452 461	30+ years
R66	SiteOf Arg1:T436 Arg2:T435	
R67	SiteOf Arg1:T436 Arg2:T434	
R68	SiteOf Arg1:T436 Arg2:T438	
R8	SiteOf Arg1:T447 Arg2:T441	
R10	SiteOf Arg1:T447 Arg2:T443	
R11	SiteOf Arg1:T447 Arg2:T444	
T469	Pathology 1205 1208	IHC
A37	IntentVal T469 diagnosis
T571	RadPathResult 1209 1210	0
A205	RadPathResultVal T571 Others
R69	ResultOfTest Desc:T571 Test:T469	
A206	IntentVal T26 diagnosis
T572	RadPathResult 1223 1226	1.7
R70	ResultOfTest Desc:T572 Test:T26	
T573	Site 1414 1420	breast
T574	Laterality 1408 1413	right
R71	LateralityOfSite Arg1:T574 Arg2:T573	
R72	SiteOf Arg1:T573 Arg2:T473	
T575	Pathology 1557 1570	mitotic count
A207	EpisodeDescription T575 FirstOccurrence
T576	Histology 1704 1708	DCIS
A208	NegationModalityVal T576 negated
A209	EpisodeDescription T576 FirstOccurrence
T493	Pathology 1932 1935	IHC
T577	RadPathResult 1936 1937	1
T578	Pathology 1939 1943	FISH
T579	RadPathResult 1950 1953	2.1
R74	ResultOfTest Desc:T579 Test:T578	
R73	ResultOfTest Desc:T577 Test:T493	
R75	TreatmentAdministeredForProblem Treatment:T56 Prob:T497	
T501	Site 2525 2531	breast
T580	ProcedureName 2532 2539	surgery
A59	IntentVal T580 DiagnosisAndTreatment
A210	TreatmentTypeVal T580 local
R40	SiteOf Arg1:T501 Arg2:T580	
R76	SiteOf Arg1:T501 Arg2:T500	
T581	ClinicalCondition 2620 2628	Cataract
A211	ChronicVal T581 chronic
A212	ContinuityVal T581 stable
T582	ClinicalCondition 2634 2664	CHF (congestive heart failure)
A213	ChronicVal T582 chronic
A214	ContinuityVal T582 stable
T583	ClinicalCondition 2670 2698	CKD (chronic kidney disease)
A215	ChronicVal T583 chronic
A216	ContinuityVal T583 stable
T584	ClinicalCondition 2703 2731	Chronic kidney disease (CKD)
A217	ChronicVal T584 chronic
A218	ContinuityVal T584 stable
T585	ClinicalCondition 2894 2918	Coronary atherosclerosis
A219	ChronicVal T585 chronic
A220	ContinuityVal T585 stable
T586	ClinicalCondition 2971 2988	Diabetes mellitus
A221	ChronicVal T586 chronic
A222	ContinuityVal T586 stable
T587	ClinicalCondition 3006 3044	GERD (gastroesophageal reflux disease)
A223	ChronicVal T587 chronic
A224	ContinuityVal T587 stable
T588	ClinicalCondition 3050 3058	Glaucoma
A225	NegationModalityVal T588 uncertain_in_past
A226	ChronicVal T588 chronic
A227	ContinuityVal T588 stable
T589	ClinicalCondition 3075 3093	HTN (hypertension)
A228	ChronicVal T589 chronic
A229	ContinuityVal T589 stable
T590	ClinicalCondition 3099 3111	Hypertension
A230	ChronicVal T590 chronic
A231	ContinuityVal T590 stable
T591	ClinicalCondition 3139 3153	hyperlipidemia
A232	ChronicVal T591 chronic
A233	ContinuityVal T591 stable
T592	ClinicalCondition 3174 3203	SBO (small bowel obstruction)
A234	ChronicVal T592 non-chronic
A235	ContinuityVal T592 stopped
T593	ClinicalCondition 3430 3449	Sick sinus syndrome
A236	ChronicVal T593 chronic
A237	ContinuityVal T593 stable
T594	ProcedureName 3512 3536	BIOPSY / EXCISION BREAST
T595	ProcedureName 3543 3558	CHOLECYSTECTOMY
T596	ProcedureName 3565 3575	MASTECTOMY
T597	Datetime 3582 3592	10/25/2016
T598	Laterality 3576 3581	Right
R77	HappensAtOnDuring Arg1:T597 Arg2:T596	
T599	Datetime 3618 3622	1998
T600	ProcedureName 3597 3616	PACEMAKER INSERTION
R78	HappensAtOnDuring Arg1:T600 Arg2:T599	
T601	ProcedureName 3627 3653	SENTINEL LYMPH NODE BIOPSY
T602	Datetime 3660 3670	10/25/2016
T603	Laterality 3654 3659	Right
R79	HappensAtOnDuring Arg1:T602 Arg2:T601	
T604	ClinicalCondition 3729 3735	Stroke
A238	ExperiencerVal T604 family
T605	Age 3770 3772	40
T606	Age 3785 3787	43
T607	ClinicalCondition 3792 3798	Stroke
A241	ExperiencerVal T607 family
T608	ClinicalCondition 3811 3819	Diabetes
A242	ExperiencerVal T608 family
T609	ClinicalCondition 3831 3840	Arthritis
A243	ExperiencerVal T609 family
T610	ClinicalCondition 3852 3858	Stroke
A244	ExperiencerVal T610 family
T611	Age 3866 3868	68
T612	Datetime 3873 3883	March 2013
R80	HappensAtOnDuring Arg1:T610 Arg2:T612	
T613	ClinicalCondition 3888 3902	Stomach cancer
A246	ExperiencerVal T613 family
T614	ClinicalCondition 3931 3945	Uterine cancer
A247	ExperiencerVal T614 family
T615	Age 3960 3962	37
T616	Age 3975 3977	39
T617	ClinicalCondition 3982 3991	Blindness
A250	NegationModalityVal T617 negated
A251	ExperiencerVal T617 family
T618	ClinicalCondition 4004 4013	Amblyopia
A252	NegationModalityVal T618 negated
T619	ClinicalCondition 4026 4035	Cataracts
A253	NegationModalityVal T619 negated
T620	ClinicalCondition 4048 4056	Glaucoma
A254	NegationModalityVal T620 negated
T621	ClinicalCondition 4069 4082	Macular degen
A255	NegationModalityVal T621 negated
T622	ClinicalCondition 4095 4113	Retinal detachment
A256	NegationModalityVal T622 negated
T623	ClinicalCondition 4126 4136	Strabismus
A257	NegationModalityVal T623 negated
T624	TreatmentType 4796 4799	HRT
A258	NegationModalityVal T624 negated
T625	Age 18885 18887	81
A260	BiomarkerResultVal T533 Negative
T531	BiomarkerResult 19064 19072	negative
A143	EpisodeDescription T531 FirstOccurrence
A261	BiomarkerResultVal T531 Negative
T536	TumorCharacteristics 19491 19495	TNBC
R81	ExclusionCriteriaFor Arg1:T544 Arg2:T542	
T551	BiomarkerResult 20176 20184	negative
A262	BiomarkerResultVal T551 Negative
T626	ClinicalCondition 20192 20198	cancer
A263	ChronicVal T626 non-chronic
A264	ContinuityVal T626 stable
A265	NegationModalityVal T56 affirmed
A266	TreatmentContinuityVal T56 finished
T627	ClinicalCondition 19254 19260	cancer
A267	NegationModalityVal T627 affirmed
A268	ChronicVal T627 non-chronic
A269	ContinuityVal T627 stable
T628	ClinicalCondition 19413 19419	cancer
A270	TreatmentTypeVal T542 adjuvant
R82	TestOrProcedureReveals Test:T457 Desc:T462	
R83	TestOrProcedureReveals Test:T457 Desc:T463	
R84	TestOrProcedureReveals Test:T457 Desc:T465	
R85	TestOrProcedureReveals Test:T457 Desc:T467	
R86	TestOrProcedureReveals Test:T469 Desc:T467	
R87	TestOrProcedureReveals Test:T26 Desc:T467	
R88	SiteOf Arg1:T482 Arg2:T483	
R14	SiteOf Arg1:T447 Arg2:T445	
R16	TestOrProcedureReveals Test:T493 Desc:T489	
R89	TestOrProcedureReveals Test:T578 Desc:T489	
A271	IntentVal T417 staging
T446	Site 19073 19079	breast
R90	SiteOf Arg1:T446 Arg2:T532	
T449	BiomarkerName 19231 19237	triple
R91	BiomarkerRel Arg1:T449 Arg2:T533	
T629	BiomarkerName 19057 19063	triple
R92	BiomarkerRel Arg1:T629 Arg2:T531	
T630	Site 19247 19253	breast
R93	SiteOf Arg1:T630 Arg2:T627	
T631	BiomarkerName 19390 19396	triple
R94	BiomarkerRel Arg1:T631 Arg2:T534	
T632	Site 19406 19412	breast
R95	SiteOf Arg1:T632 Arg2:T628	
T633	BiomarkerName 20169 20175	triple
R96	BiomarkerRel Arg1:T633 Arg2:T551	
T634	Site 20185 20191	breast
R97	SiteOf Arg1:T634 Arg2:T626	
A272	IntentVal T493 diagnosis
A273	IntentVal T578 diagnosis
R98	SiteOf Arg1:T446 Arg2:T529	
R99	SiteOf Arg1:T446 Arg2:T629	
R100	SiteOf Arg1:T446 Arg2:T530	
R101	TestOrProcedureReveals Test:T473 Desc:T481	
A274	RadPathResultVal T479 Others
T494	Pathology 2020 2024	Ki67
A275	IntentVal T494 others
T635	RadPathResult 2036 2065	(<5% to 25-30%; average ~15%)
A276	RadPathResultVal T635 Others
R102	ResultOfTest Desc:T635 Test:T494	
R103	TestOrProcedureReveals Test:T473 Desc:T576	
A277	RadPathResultVal T575 Others
R104	ResultOfTest Desc:T479 Test:T575	
T636	Site 79 85	breast
R105	SiteOf Arg1:T636 Arg2:T423	
A278	DiseaseStateVal T407 progression-recurrence
A279	DiseaseStateVal T554 progression-others
A280	DiseaseStateVal T404 progression-recurrence
R106	SizeOf Arg1:T435 Arg2:T434	
R107	SizeOf Arg1:T452 Arg2:T451	
R108	SizeOf Arg1:T444 Arg2:T443	
R109	SizeOf Arg1:T476 Arg2:T478	
R110	SizeOf Arg1:T485 Arg2:T484	
T637	ap_end 21028 21036	options.
T638	ap_start 18852 18862	Assessment
T639	hpi_start 0 2	ID
T640	hpi_end 2532 2540	surgery.
R111	BeginsOnOrAt Arg1:T496 Arg2:T56	
